Dupont Capital Management’s Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share CTV.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-624
Closed -$1K 1796
2021
Q4
$1K Buy
+624
New +$776 ﹤0.01% 1703

Other funds holding CTV.WS

Dupont Capital Management's CTV.WS Position: Q1 2022 in Review

Dupont Capital Management sold out of Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) in Q1 2022, closing a stake of 624 shares — an estimated $1K sold.

Dupont Capital Management first reported a position in CTV.WS in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 22 funds tracked by Wall St. Rank hold CTV.WS as of Q1 2022.

  • Dupont Capital Management reported no remaining Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q1 2022 after selling out during the quarter.
  • Dupont Capital Management sold 624 Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q1 2022, an estimated $1K.
  • Dupont Capital Management first reported a position in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q4 2021 and held it in 1 quarter.
  • Dupont Capital Management's Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $1K in Q4 2021.
  • 22 funds tracked by Wall St. Rank held Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q1 2022.

Based on Dupont Capital Management's 13F filing for Q1 2022, filed 27 Apr 2022.